Liontos M - Search Results

1

Spontaneous tumor lysis syndrome in patients with solid tumors: a scoping review of the literature.

Papapanou M, Athanasopoulos AE, Georgiadi E, Maragkos SA, Liontos M, Ziogas DC, Damaskos D, Schizas D. Papapanou M, et al. Among authors: liontos m. Med Oncol. 2023 Jul 11;40(8):233. doi: 10.1007/s12032-023-02108-4. Med Oncol. 2023. PMID: 37432468 Free PMC article. Review.

2

Factors contributing to inappropriate ordering of tests in an academic medical department and the effect of an educational feedback strategy.

Miyakis S, Karamanof G, Liontos M, Mountokalakis TD. Miyakis S, et al. Among authors: liontos m. Postgrad Med J. 2006 Dec;82(974):823-9. doi: 10.1136/pgmj.2006.049551. Postgrad Med J. 2006. PMID: 17148707 Free PMC article.

3

The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis.

Evangelou K, Bartkova J, Kotsinas A, Pateras IS, Liontos M, Velimezi G, Kosar M, Liloglou T, Trougakos IP, Dyrskjot L, Andersen CL, Papaioannou M, Drosos Y, Papafotiou G, Hodny Z, Sosa-Pineda B, Wu XR, Klinakis A, Ørntoft T, Lukas J, Bartek J, Gorgoulis VG. Evangelou K, et al. Among authors: liontos m. Cell Death Differ. 2013 Nov;20(11):1485-97. doi: 10.1038/cdd.2013.76. Epub 2013 Jul 12. Cell Death Differ. 2013. PMID: 23852374 Free PMC article.

4

The roles of p27(Kip1) and DNA damage signalling in the chemotherapy-induced delayed cell cycle checkpoint.

Liontos M, Velimezi G, Pateras IS, Angelopoulou R, Papavassiliou AG, Bartek J, Gorgoulis VG. Liontos M, et al. J Cell Mol Med. 2010 Sep;14(9):2264-7. doi: 10.1111/j.1582-4934.2010.01145.x. Epub 2010 Oct 11. J Cell Mol Med. 2010. PMID: 20716117 Free PMC article.

5

Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.

Gyftaki R, Liacos C, Politi E, Liontos M, Saltiki K, Papageorgiou T, Thomakos N, Haidopoulos D, Rodolakis A, Alevizaki M, Bamias A, Dimopoulos A. Gyftaki R, et al. Among authors: liontos m. Int J Gynecol Cancer. 2014 Jun;24(5):851-6. doi: 10.1097/IGC.0000000000000139. Int J Gynecol Cancer. 2014. PMID: 24844218

6

Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells.

Weisz L, Damalas A, Liontos M, Karakaidos P, Fontemaggi G, Maor-Aloni R, Kalis M, Levrero M, Strano S, Gorgoulis VG, Rotter V, Blandino G, Oren M. Weisz L, et al. Among authors: liontos m. Cancer Res. 2007 Mar 15;67(6):2396-401. doi: 10.1158/0008-5472.CAN-06-2425. Cancer Res. 2007. PMID: 17363555

7

Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-κB pathway.

Sigala F, Savvari P, Liontos M, Sigalas P, Pateras IS, Papalampros A, Basdra EK, Kolettas E, Papavassiliou AG, Gorgoulis VG. Sigala F, et al. Among authors: liontos m. J Cell Mol Med. 2010 Sep;14(9):2273-80. doi: 10.1111/j.1582-4934.2010.01082.x. J Cell Mol Med. 2010. PMID: 20455997 Free PMC article.

8

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer.

Rose TL, Deal AM, Ladoire S, Créhange G, Galsky MD, Rosenberg JE, Bellmunt J, Wimalasingham A, Wong YN, Harshman LC, Chowdhury S, Niegisch G, Liontos M, Yu EY, Pal SK, Chen RC, Wang AZ, Nielsen ME, Smith AB, Milowsky MI; Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators. Rose TL, et al. Among authors: liontos m. Bladder Cancer. 2016 Oct 27;2(4):405-413. doi: 10.3233/BLC-160072. Bladder Cancer. 2016. PMID: 28035321 Free PMC article.

9

Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins.

Sideridou M, Zakopoulou R, Evangelou K, Liontos M, Kotsinas A, Rampakakis E, Gagos S, Kahata K, Grabusic K, Gkouskou K, Trougakos IP, Kolettas E, Georgakilas AG, Volarevic S, Eliopoulos AG, Zannis-Hadjopoulos M, Moustakas A, Gorgoulis VG. Sideridou M, et al. Among authors: liontos m. J Cell Biol. 2011 Dec 26;195(7):1123-40. doi: 10.1083/jcb.201108121. J Cell Biol. 2011. PMID: 22201124 Free PMC article.

10

SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1.

Woodcock SA, Rooney C, Liontos M, Connolly Y, Zoumpourlis V, Whetton AD, Gorgoulis VG, Malliri A. Woodcock SA, et al. Among authors: liontos m. Mol Cell. 2009 Mar 13;33(5):639-53. doi: 10.1016/j.molcel.2009.02.012. Mol Cell. 2009. PMID: 19285946 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page